Fulltext
Full text is available in PDF.
International Journal of Cancer Management
The Official Journal of Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences
Authors
Background: In this study we have evaluated the prognostic impact of Metastatic Lymph node Ratio (MLR) in gastric cancer patients whose have undergone curative surgical resection.
Methods: A total of 121 patients with gastric adenocarcinoma undergoing curative surgical resection (R0) in our institutions between 2003 and 2010 have been included in this study. MLR has classified into 3 groups as follows: MLR0; 0, MLR1; >0-0.33 and MLR2; 0.34-1. We have used Kaplan-Meier method to calculate survival rates and log rank test to compare survival curves between groups. Cox proportional hazards model has utilized for multivariate analysis.
Results: The median age of patients was 65 (range; 32 to 89) with a male to female ratio of 91/30 (3.03). 88 patients have undergone total gastrectomy (72.5%) and 33 subtotal gastrectomy (27.5%). With a median total retrieved lymph node of 11 (range; 6 to 44), the MLR0 to MLR2 has calculated in 28(23.1%), 31(25.6%) and 62 (51.2%) patients respectively. MLR2 (>0.33) has significantly associated with higher Tumor stage (T1-T2: 18.7% vs. T3: 56.2%, p=0.002). With a median follow up time of 12 months (range; 2-88), the 3-year survival in patients with MLR0, MLR1 and MLR2 was 75.1%, 54.8% and 9.5% respectively (p value<0.001). Tumor location (p<0.01), tumor stage (p<0.01) and lymph node stage (p<0.001) were also significant predictor of survival. MLR has also significant correlated with survival in 91 patients with less than 15 obtained lymph nodes (p<0.001). Cox-regression multivariate analysis has shown MLR as the most important and independent predictor of survival (p<0.001).
Conclusion: MLR with cutoff point of 0.33 could be used as an independent prognostic factor in gastric cancer patients whose have undergone curative surgical resection. This factor could effectively predict survival even in cases with insufficient (<15) retrieved lymph nodes.
© 2014, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Negahi A, Akbari ME, Motaghi P, Akbari A, Riazi H, et al. Assessment on the Prognostic Validity of Dissected and Positive Lymph Node Counts and Lymph Node Ratio in Patients with Gastric Cancer: A Multi-central Cohort Study. Int J Cancer Manag. 2021;14(9):e114118. doi: https://doi.org/10.5812/ijcm.114118
Attarian M, Aliakbarian M, Taghizadeh kermani A, Attarian F, Amouian S, et al. Predictive Value of Lymph Node Ratio in Patients with Pancreatic Cancer Treated with Pancreatoduodenectomy. Int J Cancer Manag. 2021;14(3):e104861. doi: https://doi.org/10.5812/ijcm.104861
Roshnaei G, Sedighi S, Safari M, Faradmal J. Estimated survival time in gastric cancer patients and its associated factors. koomesh. 2012;14(1):e152548. doi:
Paknazar F, mahmoudi M, Mohammad K, Zeraati H, Mansournia MA, et al. Postoperative net survival of gastric adenocarcinoma at Imam Khomeini hospital in Tehran: Estimating in a relative-survival framework. koomesh. 2018;20(4):e153005. doi:
Taghavi A, Khorsand A, Saberafsharian M, Sahabi R, Beiraghdar M, et al. Gastric Cancer: Correlation of Histologic Type with Commonly Used Prognostic Variables. Int J Cancer Manag. 2023;16(1):e134832. doi: https://doi.org/10.5812/ijcm-134832
Last Update: 1 week ago
Last Update: 1 week ago
Last Update: 1 week ago
Last Update: 4 hours ago
Last Update: 7 hours ago
Last Update: 5 days ago